AU1205692A - Percutaneous absorption promoter composition and external preparation for percutaneous administration - Google Patents

Percutaneous absorption promoter composition and external preparation for percutaneous administration

Info

Publication number
AU1205692A
AU1205692A AU12056/92A AU1205692A AU1205692A AU 1205692 A AU1205692 A AU 1205692A AU 12056/92 A AU12056/92 A AU 12056/92A AU 1205692 A AU1205692 A AU 1205692A AU 1205692 A AU1205692 A AU 1205692A
Authority
AU
Australia
Prior art keywords
percutaneous
external preparation
absorption promoter
promoter composition
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12056/92A
Other languages
English (en)
Inventor
Kenji Mori
Iwao Nozawa
Syuji Sato
Hisashi Yamaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Publication of AU1205692A publication Critical patent/AU1205692A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
AU12056/92A 1991-05-11 1992-02-24 Percutaneous absorption promoter composition and external preparation for percutaneous administration Abandoned AU1205692A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3-135421 1991-05-11
JP13542191 1991-05-11

Publications (1)

Publication Number Publication Date
AU1205692A true AU1205692A (en) 1992-12-30

Family

ID=15151343

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12056/92A Abandoned AU1205692A (en) 1991-05-11 1992-02-24 Percutaneous absorption promoter composition and external preparation for percutaneous administration

Country Status (3)

Country Link
AU (1) AU1205692A (ja)
TW (1) TW206918B (ja)
WO (1) WO1992020376A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2185227A1 (en) * 1994-03-11 1995-09-14 Michiari Hashimoto Percutaneous absorption applying sheet comprising acid salt of morphine
CA2144591A1 (en) * 1994-03-15 1995-09-16 Koji Doi Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US6464992B2 (en) * 2000-04-14 2002-10-15 University Of Kentucky Research Foundation Topical micronutrient delivery system and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58185514A (ja) * 1982-04-22 1983-10-29 Hisamitsu Pharmaceut Co Inc 新規な局所用消炎鎮痛ゲル状クリ−ム剤
US4797272A (en) * 1985-11-15 1989-01-10 Eli Lilly And Company Water-in-oil microemulsions for cosmetic uses

Also Published As

Publication number Publication date
TW206918B (ja) 1993-06-01
WO1992020376A1 (en) 1992-11-26

Similar Documents

Publication Publication Date Title
AU1298788A (en) Percutaneous absorption promoter and dermatologic preparation for external use
AU1819288A (en) Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
AU2087992A (en) Pharmaceutical combination formulation
AU7177794A (en) Absorption enhancers for drug administration
AU1453488A (en) Novel compositions for therapeutic percutaneous embolization and the use thereof
AU3775695A (en) Improved sunscreen compositions
ZA9410333B (en) Percutaneous pharmaceutical preparation
AU2822892A (en) Oxygen-scavenging composition
AU3152993A (en) Improvements in the administration of aerosol compounds
AU8649191A (en) Composition containing steroid derivatives
AU7020787A (en) Azacycloalkane derivatives, absorption promoters containing the derivatives as the effective ingredient and external preparations containing the absorption promoters
AU3158493A (en) Sunscreen compositions
AU2960892A (en) Immunogen composition
AU1205792A (en) Percutaneous administration and absorption promoter composition and external preparation for percutaneous administration
AU1337692A (en) Composition for relieving skin irritation and external preparation for percutaneous administration containing the same
AU1227292A (en) Pharmaceutical antitussive compositions
AU1090692A (en) Antiperspirant composition
AU2392492A (en) Pharmaceutical composition
AU2318492A (en) Sunscreen composition
AU4075893A (en) Novel taxane derivatives, their preparation and compositions containing same
AU1189392A (en) Pharmaceutical agent
AU1205692A (en) Percutaneous absorption promoter composition and external preparation for percutaneous administration
AU9097991A (en) Anticancer composition and compound
AU1740292A (en) Triphenylethylene derivative and pharmaceutical preparation containing the same
AU2808492A (en) Medicament composition for topical application